|
|
Other links at Articles > Business of Medicine |
| 1. |
Ethics, Evidence, and Cost in Newborn Screening
|
|
|
What are the ethical and policy issues that arise in debates on public newborn screening programs? The experience in Mississippi serves to highlight an important ethical issue in child health policy.
The Hastings Center Report
|
| 2. |
InterMune Lung Disease Medicine on Fast Track
|
|
|
Biotechnology company InterMune Inc on Monday said U.S. regulators granted fast-track status for the development of pirfenidone to treat idiopathic pulmonary fibrosis (IPF), a deadly lung disease. Reuters Health Information
|
|
|